CEOCFO-Press Release

Featuring: publicly traded & venture capital companies on the U.S. (NYSE, NASDAQ, AMEX & OTC: BB) and Canadian (TSX & TSX-V) stock exchanges, Investment & Money Management Ideas.
Press Release - Concert Pharmaceuticals, Inc. (Private)
	“The vision behind Concert is to take a different tack at drug discovery that would enable the creation of new chemical entities (NCEs), first-and best-in-class new medicines, in a way that substantially reduces the risks associated with current drug development approaches and increases the likelihood of their successful commercial development.” - Roger Tung, Ph.D. (Interview published February 19, 2009)
The Most Powerful Name In Corporate News and Information.
CURRENT ISSUE \| COVER ARCHIVES \| INDEX \| CONTACT \| FINANCIALS \| MARKETING SERVICES \| HOME PAGE

CEOCFO-Members Login Become A Member!	Concert Pharmaceuticals to Present at the Cowen and Company 29^th Annual Health Care Conference on March 16, 2009 March 9, 2009 LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. announced today that Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present at the Cowen and Company 29^th Annual Health Care Conference on Monday, March 16, 2009 at 11:00 a.m. Eastern Time. The conference will be held March 16-19, 2009 at The Boston Marriott Copley Place in Boston , Massachusetts . About Concert Concert Pharmaceuticals is a clinical-stage biotechnology company focused on the application of deuterium chemistry to create novel small molecule drugs. Concert’s approach leverages known activity and safety of existing drugs to reduce time, risk and expense of drug research and development. The Company’s pipeline is focused on infectious disease, renal disease, cardiovascular disease, and cancer, among o the rs. Founded in 2006, Concert has raised more than $96 million from leading venture capitalists and institutional investors. For more information on Concert Pharmaceuticals, please visit www.concertpharma.com. CoNCERT and CoNCERT Pharmaceuticals are trademarks of Concert Pharmaceuticals, Inc. Contacts Concert Pharmaceuticals Justine E. Koenigsberg, 781-674-5284 Senior Director, Corporate Communications and Investor Relations

ceocfointerviews.com does not purchase or make
recommendation on stocks based on the interviews published.

Concert Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference on March 16, 2009

Concert Pharmaceuticals to Present at the Cowen and Company 29^th Annual Health Care Conference on March 16, 2009